Treating tardive dyskinesia with essential fatty acid compositio

Details Treating tardive dyskinesia with essential fatty acid compositio Treating tardive dyskinesia with essential fatty acid compositio

1990-09-25

1992-06-09

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514560, A61K 3120, A61K 31355

Patent

active

051207605

ABSTRACT:
Method of, and preparations of medicaments for, treating schizophrenia and/or associated tardive dyskinesia by combining an essential fatty acid selected from GLA and higher n-6 series acides with an essential fatty acid selected from stearidonic acid and higher n-3 series acids in effective daily amounts of 10 mg and 50 g of each acid.

REFERENCES:
patent: 4273763 (1981-06-01), Horrobin
patent: 4302447 (1981-11-01), Horrobin
patent: 4738985 (1988-04-01), Kluger et al.
patent: 4780456 (1988-10-01), Pistolesi
patent: 4826877 (1989-05-01), Stewart et al.
patent: 4977187 (1990-12-01), Horrobin

Affiliated with

Also associated with

Rating

Treating tardive dyskinesia with essential fatty acid compositio does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treating tardive dyskinesia with essential fatty acid compositio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating tardive dyskinesia with essential fatty acid compositio will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1804870